Baxter Names John Rogers as CFO, Filling Key Leadership Gap
BAX sits 67% above its 52-week low of $15.73.
Summary
Baxter appointed John Rogers as permanent CFO effective October 1, 2026, with a compensation package including a $2.8 million sign-on bonus and approximately $7.9 million in equity grants. CEO Andrew Hider will serve as interim CFO for the two-week gap after the current interim CFO departs on September 15.
Key Events · Executive and Board Changes · BAX
-
Permanent CFO Appointed
John Rogers, former CFO of Smith+Nephew and WPP, will become Baxter's CFO effective October 1, 2026, reporting to CEO Andrew Hider.
-
Compensation Package Details
Rogers will receive a $925,000 base salary, 100% target bonus, $4 million target annual equity, two off-cycle equity grants totaling approximately $7.86 million, and a $2.83 million sign-on bonus.
-
Interim Leadership Bridge
CEO Andrew Hider will serve as interim CFO from September 15 to October 1, 2026, after current interim CFO Anita Zielinski departs. Bernie Heine will serve as interim CAO and Controller.
-
Guidance Reaffirmed
Baxter reiterated its full-year 2026 financial outlook provided on July 30, 2026, signaling stability during the leadership transition.
Analysis · BAX · Industrial Applications And Services
Baxter has appointed John Rogers as its new CFO effective October 1, 2026, ending a period of interim leadership. Rogers brings CFO experience from Smith+Nephew and WPP, and his compensation package includes a $2.8 million sign-on bonus and equity grants worth roughly $7.9 million. The appointment follows the resignation of interim CFO Anita Zielinski announced two weeks ago, and the company has arranged for CEO Andrew Hider to serve as interim CFO during the two-week gap. This resolves a key leadership uncertainty for a company in the midst of a turnaround and balance-sheet strengthening effort.
At the time of this filing, BAX was trading at $26.20 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $13.4B. The 52-week trading range was $15.73 to $30.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.